Arab World vs Cameroon: Women's share of population ages 15+ living with HIV
Arab World
37.6%
in 2024
Cameroon
64.8%
in 2024
Arab World rank
15th
Cameroon rank
17th
Women's share of population ages 15+ living with HIV over time
- Arab World
- Cameroon
How they compare
Cameroon currently reports 64.8% against 37.6% in Arab World, a difference of 27.2%.
That makes Cameroon's figure about 1.7 times Arab World's.
Across all 35 years both countries report, Cameroon has been ahead every year.
Arab World ranks 15th and Cameroon ranks 17th of 20 groups.
Cameroon has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Arab World | Cameroon | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 42.1% | 56.8% | 14.7% | Cameroon |
| 2000s | 38.7% | 57.6% | 18.9% | Cameroon |
| 2010s | 37.3% | 60.0% | 22.7% | Cameroon |
| 2020s | 37.5% | 64.2% | 26.7% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher women's share of population ages 15+ living with hiv, Arab World or Cameroon?
- Cameroon, at 64.8% against 37.6% in Arab World as of 2024.
- What is the difference in women's share of population ages 15+ living with hiv between Arab World and Cameroon?
- 27.2%, with Cameroon ahead.
- How many years of comparable data are there for Arab World and Cameroon?
- 35 years are reported by both, from 1990 to 2024.
- How do Arab World and Cameroon rank globally for women's share of population ages 15+ living with hiv?
- Arab World ranks 15th and Cameroon ranks 17th of 20 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Women's share of population ages 15+ living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.